Loading...
Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
BACKGROUND: β-Thalassemia is an inherited hemoglobin disorder caused by defective synthesis of ß-globin chains. Hemoglobin (Hb) F induction is a possible therapeutic approach which can partially compensate for α and non-α globin chains imbalance. OBJECTIVES: We aimed to investigate the efficacy and...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Kowsar
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4102988/ https://ncbi.nlm.nih.gov/pubmed/25068055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/ircmj.18028 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|